FDA OKs Sunovion drug for Parkinson’s disease

FDA OKs Sunovion drug for Parkinson’s disease
The FDA approves Sunovion's Kynmobi (apomorphine hydrochloride) sublingual film for the treatment of OFF episodes in Parkinson's disease patients.Licensor Aquestive Therapeutics (NASDAQ:AQST) intends ... read more
Source: Bing NewsPublished on 2020-05-21